glp 1 updates If you're covered by the State Health Benefit Plan (SHBP) and take a weight-loss GLP-1 medication (like Wegovy or Zepbound), a change is coming. Starting February 1, 2026, SHBP will require these GLP-1 Practice Updates March 2026:

The dose recommended, according to the present invention, is 2 g/day of acetyl L-carnitine and 2 g/day of propionyl L-carnitine, and 100 mg of sildenafil once or twice a week

A warning is also being issued about the risks associated with importing and using unapproved peptide products under the Personal Importation Scheme, with healthcare practitioners urged to report non-compliance

This side effect has led to lawsuits against Novo Nordisk for not adequately warning users

Like, subscribe, tell people about this, and share this episode with a friend because you never know how that secondhand person is going to say, I know somebody who needs some help. As we do this, we help people get better